These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3034091)
1. Assessment of retinoid-induced differentiation of F9 embryonal carcinoma cells with an enzyme-linked immunoadsorbent assay for laminin: statistical comparison of dose-response curves. Williams JB; Shields CO; Brettel LM; Napoli JL Anal Biochem; 1987 Feb; 160(2):267-74. PubMed ID: 3034091 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells. Williams JB; Napoli JL Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4658-62. PubMed ID: 3860815 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of F9 embryonal carcinoma cells by synthetic retinoids: amplitude of plasminogen activator production does not depend on retinoid potency or affinity for F9 nuclear retinoic acid receptors. Bailly J; Delescluse C; Bernardon JM; Charpentier B; Martin B; Pilgrim WR; Shroot B; Darmon M Skin Pharmacol; 1990; 3(4):256-67. PubMed ID: 1964567 [TBL] [Abstract][Full Text] [Related]
4. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715 [TBL] [Abstract][Full Text] [Related]
5. Reversible effects of dibutyryl cAMP on laminin and type IV collagen secretion from retinoic acid treated F9 cells. Morita A; Kitagawa Y; Sugimoto E J Cell Physiol; 1985 Nov; 125(2):263-72. PubMed ID: 2997239 [TBL] [Abstract][Full Text] [Related]
6. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. Clifford J; Chiba H; Sobieszczuk D; Metzger D; Chambon P EMBO J; 1996 Aug; 15(16):4142-55. PubMed ID: 8861943 [TBL] [Abstract][Full Text] [Related]
8. 4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptors. Achkar CC; Derguini F; Blumberg B; Langston A; Levin AA; Speck J; Evans RM; Bolado J; Nakanishi K; Buck J; Gudas LJ Proc Natl Acad Sci U S A; 1996 May; 93(10):4879-84. PubMed ID: 8643497 [TBL] [Abstract][Full Text] [Related]
9. Increased levels of several retinoid binding proteins resulting from retinoic acid-induced differentiation of F9 cells. Eriksson U; Hansson E; Nilsson M; Jönsson KH; Sundelin J; Peterson PA Cancer Res; 1986 Feb; 46(2):717-22. PubMed ID: 3000582 [TBL] [Abstract][Full Text] [Related]
10. Sox7 plays crucial roles in parietal endoderm differentiation in F9 embryonal carcinoma cells through regulating Gata-4 and Gata-6 expression. Futaki S; Hayashi Y; Emoto T; Weber CN; Sekiguchi K Mol Cell Biol; 2004 Dec; 24(23):10492-503. PubMed ID: 15542856 [TBL] [Abstract][Full Text] [Related]
11. Embryonal carcinoma cell lines stably transfected with mRARbeta2-lacZ: sensitive system for measuring levels of active retinoids. Sonneveld E; van den Brink CE; van der Leede BJ; Maden M; van der Saag PT Exp Cell Res; 1999 Aug; 250(2):284-97. PubMed ID: 10413584 [TBL] [Abstract][Full Text] [Related]
12. Retinoic acid, dibutyryl-cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells. Martin CA; Ziegler LM; Napoli JL Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4804-8. PubMed ID: 2162058 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993 [TBL] [Abstract][Full Text] [Related]
14. Biphasic response to retinoic acid dose in differentiation of F9 cells into primitive endoderm-like cells. Miki K; Kitagawa Y Exp Cell Res; 1988 Dec; 179(2):344-51. PubMed ID: 2847934 [TBL] [Abstract][Full Text] [Related]
15. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Kondo K; Tsuneizumi K; Watanabe T; Oishi M Cancer Res; 1991 Oct; 51(19):5398-404. PubMed ID: 1680548 [TBL] [Abstract][Full Text] [Related]
16. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids. Li Y; Glozak MA; Smith SM; Rogers MB Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260 [TBL] [Abstract][Full Text] [Related]
17. Quantitative switch in integrin expression accompanies differentiation of F9 cells treated with retinoic acid. Burdsal CA; Lotz MM; Miller J; McClay DR Dev Dyn; 1994 Dec; 201(4):344-53. PubMed ID: 7894073 [TBL] [Abstract][Full Text] [Related]
18. Topical and systemic effects of retinoids on horn-filled utriculus size in the rhino mouse. A model to quantify "antikeratinizing" effects of retinoids. Mezick JA; Bhatia MC; Capetola RJ J Invest Dermatol; 1984 Aug; 83(2):110-3. PubMed ID: 6206163 [TBL] [Abstract][Full Text] [Related]
19. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands. Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863 [TBL] [Abstract][Full Text] [Related]
20. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. De Luca LM FASEB J; 1991 Nov; 5(14):2924-33. PubMed ID: 1661245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]